Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Covington
Express Scripts
Moodys
Teva
Dow
Baxter
Julphar
Chubb

Generated: January 16, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tralokinumab

« Back to Dashboard

US Patents for Tralokinumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tralokinumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Tralokinumab ➤ Sign Up Meditopes and meditope-binding antibodies and uses thereof City of Hope (Duarte, CA) ➤ Sign Up
Tralokinumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Tralokinumab ➤ Sign Up Compositions and methods for treating fibrotic disease eFFECTOR Therapeutics, Inc. (San Diego, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Tralokinumab

Drugname Country Document Number Estimated Expiration Related US Patent
Tralokinumab Australia 2011312106 2030-10-08 ➤ Sign Up
Tralokinumab Australia 2012321301 2030-10-08 ➤ Sign Up
Tralokinumab Australia 2017203871 2030-10-08 ➤ Sign Up
Tralokinumab Canada 2814040 2030-10-08 ➤ Sign Up
Tralokinumab Canada 2852099 2030-10-08 ➤ Sign Up
Tralokinumab China 103501815 2030-10-08 ➤ Sign Up
Tralokinumab China 104039809 2030-10-08 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Medtronic
Harvard Business School
Queensland Health
Baxter
Fish and Richardson
Cerilliant
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.